Zygotic twins growth restriction - Causes, Treatment & When to See a Doctor

```html

What is Zygotic Twins Growth Restriction?

Zygotic twins growth restriction (also called twin growth restriction, twin intra‑uterine growth restriction or twin IUGR) refers to a condition in which one or both members of a twin pregnancy fail to achieve their expected fetal growth potential. The term “zygotic” simply indicates that the twins originated from separate fertilized eggs (dizygotic or fraternal twins); the growth restriction can affect dizygotic, monozygotic (identical) or mixed‑type pregnancies.

Normal fetal growth follows a predictable curve based on gestational age. In twin pregnancies, each fetus normally grows a little slower than a singleton because the uterus must share resources, but both should remain within the 10th percentile for weight appropriate to gestational age. When a twin’s estimated fetal weight (EFW) falls below this threshold, or when there is a marked size discrepancy (often defined as a discordance of ≥20 %** between the two twins), clinicians diagnose growth restriction.

Growth restriction is not just a measurement problem—it reflects underlying problems with oxygen or nutrient delivery, placental function, or fetal health, and it is associated with higher rates of pre‑term birth, stillbirth, and long‑term developmental issues. Early recognition and careful monitoring are essential for optimizing outcomes for both twins.

Common Causes

Growth restriction in twins is usually multifactorial. Below are the most frequent maternal, placental, and fetal contributors (listed in no particular order):

• Placental insufficiency – The placenta cannot supply enough oxygen and nutrients, often because of a single placenta shared by both twins (monochorionic) or unequal sharing of a larger placenta (dichorionic).
• Twin‑to‑Twin Transfusion Syndrome (TTTS) – A complication of monochorionic twins where blood flows disproportionately from one twin (donor) to the other (recipient), causing donor growth restriction.
• Maternal hypertension or pre‑eclampsia – High blood pressure reduces uteroplacental blood flow.
• Maternal diabetes (especially uncontrolled) – Can lead to abnormal placental development and vascular disease.
• Maternal smoking, alcohol or illicit drug use – Directly impairs fetal oxygenation and nutrient delivery.
• Uterine anomalies or fibroids – Physical constraints limit space for optimal fetal growth.
• Infections – TORCH infections (Toxoplasmosis, Other, Rubella, Cytomegalovirus, Herpes) or maternal viral illnesses can impair growth.
• Chromosomal or genetic abnormalities – Certain syndromes (e.g., Turner syndrome, trisomy 21) are associated with restricted growth.
• Maternal malnutrition or severe anemia – Inadequate maternal stores limit fetal nutrition.
• Multiple gestation itself – Even without overt pathology, the competition for limited uterine blood flow makes twins more vulnerable than singletons.

Associated Symptoms

Most growth‑restricted twins do **not** cause symptoms that the pregnant person can feel. However, some signs may be noticed during routine prenatal visits or through specific testing:

• Abnormal findings on routine ultrasound (EFW < 10th percentile, abnormal Doppler waveforms)
• Discrepancy in abdominal measurements between twins (one appears significantly smaller)
• Decreased fetal movements reported by the mother, especially for the smaller twin
• Maternal hypertension, proteinuria, or signs of pre‑eclampsia
• Unexplained weight loss or poor weight gain in the mother
• Signs of TTTS on ultrasound (polyhydramnios in one sac, oligohydramnios in the other)
• Elevated maternal serum markers (e.g., abnormal AFP, hCG patterns) suggesting placental dysfunction

When to See a Doctor

Because growth restriction can progress quickly, you should contact your obstetrician or go to the emergency department if you notice any of the following:

• Sudden decrease in fetal movements for either twin (especially if < 10 movements in 2 hours).
• Severe abdominal pain, cramping, or bleeding.
• Signs of pre‑eclampsia: persistent headache, visual disturbances, swelling, or rapid weight gain.
• Rapid increase in uterine size suggesting polyhydramnios in one twin (common in TTTS).
• Persistent high blood pressure (> 140/90 mm Hg) after 20 weeks gestation.
• Any new or worsening symptoms of infection (fever, chills, flu‑like illness).

Early evaluation can prevent complications such as pre‑term birth, stillbirth, or severe neonatal morbidity.

Diagnosis

Diagnosing growth restriction in twins involves a combination of imaging, laboratory tests, and clinical assessment.

Ultrasound Evaluation

• Standard biometry – Head circumference, abdominal circumference, femur length; compared to gestational age charts for twins.
• Estimated fetal weight (EFW) – Calculated using Hadlock or similar formulas; <10th percentile = growth restriction.
• Doppler studies – Umbilical artery, middle cerebral artery, and ductus venosus waveforms assess blood flow resistance; abnormal Dopplers indicate placental insufficiency.
• Amniotic fluid volume – Oligohydramnios (low fluid) is common with growth restriction; polyhydramnios may suggest TTTS.
• Placental assessment – Size, thickness, and presence of abnormal vascular anastomoses (especially in monochorionic twins).

Maternal Laboratory Tests

• Blood pressure monitoring and urine protein (pre‑eclampsia screen).
• Complete blood count and iron studies (check for anemia).
• Screen for infections (TORCH panel, PCR for CMV, etc.) if indicated.
• Glucose tolerance test for diabetes control.

Fetal Surveillance

• Non‑stress test (NST) or biophysical profile (BPP) at least twice weekly after 28 weeks if growth restriction is confirmed.
• Serial growth scans every 1–2 weeks to track progression.

Specialist Consultation

High‑risk obstetricians, maternal‑fetal medicine (MFM) specialists, and perinatologists are typically involved. In cases of TTTS, a fetal surgeon may be consulted for laser ablation of placental vessels.

Treatment Options

Treatment focuses on optimizing fetal growth, prolonging pregnancy safely, and delivering at the optimal time. Management is individualized based on severity, gestational age, and underlying cause.

Medical Management

• Maternal nutrition optimization – High‑protein, high‑calorie diet; prenatal vitamins with adequate iron, folic acid, DHA.
• Control of maternal hypertension – Low‑dose antihypertensives safe in pregnancy (e.g., labetalol, nifedipine).
• Gestational diabetes management – Diet, glucose monitoring, insulin if needed.
• Corticosteroids – Betamethasone or dexamethasone 24 hours before anticipated pre‑term delivery (24–34 weeks) to mature fetal lungs.
• Tocolytics – May be used briefly if early labor threatens delivery before steroids take effect.
• Therapeutic laser surgery for TTTS – Laser photocoagulation of abnormal placental vessels improves outcomes for both twins.
• Bed rest / activity modification – Evidence is mixed, but some clinicians advise reduced physical stress for severe placental insufficiency.

Delivery Planning

• If growth restriction is severe (EFW < 5th percentile, abnormal Dopplers) and gestational age is ≥ 32 weeks, many specialists recommend delivery—often via cesarean section—to limit intra‑uterine demise.
• For < 32 weeks, the goal is to balance fetal maturity against risk; steroids and close monitoring are used before electing delivery.
• In cases of TTTS, delivery may be scheduled after laser therapy once both twins are stable.

Home & Lifestyle Support

• Stay hydrated; aim for at least 2‑3 L of fluid daily unless contraindicated.
• Quit smoking and avoid alcohol or recreational drugs.
• Daily moderate activity (walking) unless advised otherwise by your provider.
• Attend all scheduled prenatal appointments and keep a fetal movement diary.

Prevention Tips

While you cannot change the fact that you are carrying twins, several steps can reduce the risk or severity of growth restriction:

• Pre‑conception health – Achieve a healthy weight, control chronic conditions (hypertension, diabetes), and take prenatal vitamins with folic acid.
• Avoid teratogens – No smoking, alcohol, or illicit drugs.
• Early prenatal care – First‑trimester ultrasound to confirm chorionicity; early detection of placental problems.
• Optimal nutrition – Balanced diet rich in protein, iron, calcium, and omega‑3 fatty acids; consider consultation with a registered dietitian experienced in high‑risk pregnancies.
• Regular blood pressure checks – Home monitoring may help detect hypertension early.
• Vaccinations – Flu vaccine and Tdap during pregnancy reduce infection‑related complications.
• Stress management – Adequate sleep, relaxation techniques, and psychosocial support.
• Follow‑up after any infection – Prompt treatment of urinary tract infections, respiratory infections, or other maternal illnesses.

Emergency Warning Signs

---

**Discordance = (Weight of larger twin – weight of smaller twin) ÷ weight of larger twin × 100 %**

Sources: Mayo Clinic, American College of Obstetricians and Gynecologists (ACOG), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), World Health Organization (WHO), Cleveland Clinic, and peer‑reviewed articles from Obstetrics & Gynecology and American Journal of Obstetrics & Gynecology (2022‑2024).

```